International pharmaceutical company (representative office of a foreign manufacturer) :: Consumers survey results of for 3 quarter of 2024

Consumers survey results of for 3 quarter of 2024 in category

Pharmaceuticals with no prescription: International pharmaceutical company (representative office of a foreign manufacturer)

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	Bayer Consumer Health	100.00%	5

2.	Berlin-Chemie	50.00%	2.50

2.	Bionorica	50.00%	2.50

2.	Delta Medical	50.00%	2.50

2.	Heel	50.00%	2.50

2.	Johnson & Johnson	50.00%	2.50

–.	Abbott	0.00%	0

–.	Acino	0.00%	0

–.	Alvogen	0.00%	0

–.	Egis	0.00%	0

–.	esparma	0.00%	0

–.	Euromedex	0.00%	0

–.	Grindex	0.00%	0

–.	GSK Consumer Healthcare (GlaxoSmithKline)	0.00%	0

–.	JGL (Jadran)	0.00%	0

–.	KRKA	0.00%	0

–.	Meda	0.00%	0

–.	Mega Lifesciences	0.00%	0

–.	Movi Health	0.00%	0

–.	Naturwaren (Naturprodukt Vega (Dr. Theiss Naturwaren GmbH))	0.00%	0

–.	Polpharma	0.00%	0

–.	Reckitt Benckiser	0.00%	0

–.	Sandoz	0.00%	0

–.	Sanofi	0.00%	0

–.	Servier	0.00%	0

–.	Sopharma	0.00%	0

–.	Stada	0.00%	0

–.	Sun Pharma	0.00%	0

–.	Takeda	0.00%	0

–.	Teva	0.00%	0

This rating reflects the current interim results of the study of public opinion as on 11/03/2024 11:14:27 and it’s not yet final.

Strictly prohibited any use and reproduction of unfinished voting results without link to the source, without clear explanation of the methodology of the “Favorites of Success” Contest and without mandatory notes that poll is still continues and this result is not yet final.